Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

297
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
297
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

324
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
324
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

388
The pathophysiology of pneumonia involves the following steps:
388
Pneumonia IV: Management01:28

Pneumonia IV: Management

410
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
410
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.3K
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

26
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
26

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptom burden, lung function, exercise tolerance and inflammation in patients post COVID-19: results from the prospective COVID-19 Chronic Morbidity (CCHROMO) study.

BMC pulmonary medicine·2026
Same author

Establishing a Cone Beam CT-Guided Bronchoscopy Program: A Stepwise Guide for Interventional Pulmonologists.

Diagnostics (Basel, Switzerland)·2026
Same author

Association of German Bronchiectasis Registry participation with disease course.

ERJ open research·2026
Same author

Pre-diagnosed sleep apnoea is linked to severe courses in community-acquired pneumonia.

ERJ open research·2026
Same author

Successful Mediastinal Cryobiopsy Using the Slim UCP190F EBUS Bronchoscope and a 25G Needle: Demonstrating the Efficacy of the Ariza-Pallares Approach.

Respirology case reports·2026
Same author

[Management of patients with chronic obstructive pulmonary disease in routine clinical practice].

Innere Medizin (Heidelberg, Germany)·2026
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Video

Updated: Aug 8, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

[Community-acquired pneumonia].

Alexander Seeger1, Gernot Rohde1

  • 1Med. Klinik 1 - Schwerpunkt Pneumologie und Allergologie, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany.

Deutsche Medizinische Wochenschrift (1946)
|March 6, 2023
PubMed
Summary
This summary is machine-generated.

Prompt diagnosis and risk-adapted therapy are crucial for community-acquired pneumonia (CAP). Early risk assessment using CRB-65 and considering comorbidities aids in managing CAP, which has significant long-term cardiovascular risks.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.9K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.1K

Related Experiment Videos

Last Updated: Aug 8, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.9K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.1K

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Pulmonology

Context:

  • Community-acquired pneumonia (CAP) presents a significant global health challenge with high morbidity and mortality.
  • The landscape of CAP diagnosis and treatment is evolving, particularly with the rise of viral pneumonias like COVID-19, influenza, and RSV.

Purpose:

  • To outline current recommendations for the diagnosis, risk stratification, and management of community-acquired pneumonia.
  • To highlight the importance of early, risk-adapted therapeutic interventions and the need for ongoing research into CAP's complexities.

Summary:

  • CAP is categorized into mild, moderate, and severe forms, necessitating early determination of treatment goals (curative vs. palliative).
  • Diagnostic tools include chest X-rays and thoracic sonography, with Streptococcus pneumoniae identified as the most common bacterial pathogen.
  • Risk assessment using the CRB-65 score, alongside evaluation of comorbidities and oxygenation, is recommended for predicting severe courses.
  • Therapeutic strategies emphasize prompt antimicrobial therapy, while acknowledging the role of antiviral and anti-inflammatory drugs in viral pneumonias, such as COVID-19.

Impact:

  • Effective management of CAP can reduce acute mortality and mitigate long-term risks, particularly cardiovascular events.
  • Further research into pathogen identification, host response, comorbidities, and long-term consequences is vital for advancing CAP care and improving patient outcomes.